Generation and selection of likely interpretations during plan recognition in task-oriented consultation systems

This paper presents a mechanism which infers a user's plans from his/her utterances by directing the inference process towards the more likely interpretations of a speaker's statements among many possible interpretations. Our mechanism uses Bayesian theory of probability to assess the likelihood of an interpretation, and it complements this assessment by taking into consideration two aspects of an interpretation: its coherence and its information content. The coherence of an interpretation is determined by the relationships between the different statements in the discourse. The information content of an interpretation is a measure of how well defined the interpretation is in terms of the actions to be performed on the basis of this interpretation. This measure is used to guide the inference process towards interpretations with higher information content. The information content of an interpretation depends on the specificity and the certainty of the inferences in it, where the certainty of an inference depends on the knowledge on which the inference is based. Our mechanism has been developed for use in task-oriented consultation systems. The particular domain that we have chosen for exploration is that of travel booking.     

Detection of failure sites by focused ion beam and nano-probing in the interconnect of three-dimensional stacked circuit structures

Focused ion beam (FIB) and nano-probing were applied for failure analysis of three-dimensional stacked circuits with copper through-silicon-vias between the stacked chips. The failure analysis was done after high temperature storage and thermal cycling tests. Passive voltage contrast in FIB allowed to pinpoint the open sites. FIB cross-sections showed the presence of opens at the bottom of the copper vias. The failure cause was suspected to be an interlayer particle, which was confirmed by optical profilometry. Nano-probing was used on another sample to pinpoint the failure location through the measurement of the local resistance within the daisy chains. The failure was traced out to be related with surface contamination.     

Responses of Dairy Cows to Exogenous Bovine Growth Hormone Administered During Early Lactation

Bovine growth hormone was administered to eight Holstein cows during two 10-d periods (commencing 20 and 60 d postpartum). Treatments involved daily subcutaneous injection of excipient (control) or of 50 IU growth hormone. Feed intake and yields of milk and milk components were measured during the last 5 d of treatment. In the first injection period, milk yield of treated cows was 6% greater than that of controls (36.2 kg/d). Fat content of milk was increased by treatment with the result that fat yield was elevated by 25%. Protein content was not altered. In the second period, milk yield increased by 12%, but composition of milk was not changed. As a result, milk energy secretion was increased by a similar amount in each treatment period (4.4 versus 4.5 Mcal/d). Feed intake was not changed in either period. During early lactation the ability of cows to increase milk yield in response to exogenous growth hormone may be limited by the supply of glucose for lactose synthesis rather than by ability to mobilize body reserves in support of lactation.     

Effect of dose of bovine growth hormone on lactation of dairy cows

We administered bovine growth hormone to six Holstein cows in a Latin square design to study the relationship between dose of growth hormone and response of milk yield. Treatments were 0, 5, 10, 25, 50, and 100 IU/day of pituitary-derived bovine growth hormone administered in once-daily subcutaneous injections. Feed intake and yield of milk and milk components were measured for the last 5 days of each 10-day injection period. Yields of milk, protein, and fat increased in a dose-responsive fashion up to 32, 27, and 46% (for the 100 IU treatment) above control (26.7, .90, and .98 kg/day). Concentration of lactose in milk was not influenced by treatment, but at larger doses of growth hormone, milk fat percent was elevated and protein percent declined. As a result, milk energy secretion in response to 100 IU/day was increased 37% from control (19.2 Mcal/day). Both energy and nitrogen balance decreased with increasing growth hormone. Limited blood samples (timed to coincide with peak concentration of growth hormone postinjection) indicated treatment did not affect concentrations of glucose or insulin in blood plasma but increased concentration of growth hormone. Concentration of nonesterified fatty acids in blood plasma was increased slightly only at the 100 IU/day dose for which energy balance was negative.     

The effect of Cu-rich sub-layer on the increased corrosion resistance of Cu-xZn alloys in chloride containing borate buffer

The electrochemical behaviour of Cu-xZn alloys, as well as their constituent metals, in a borate buffer containing chloride ions in the molar range from 0.01 to 1 M are studied. Characteristics of these materials under anodic polarization are compared and the composition and morphology of the corrosion products formed in the course of polarization experiment are analysed by SEM and EDS. X-ray photoelectron spectroscopy and electrochemical impedance measurements are used for characterization of the surface layers formed on Cu, Zn and Cu-40Zn alloy during 2-h immersion at E_oc in a borate buffer containing two different concentrations of chloride ions. New aspects of the behaviour of brass under E_oc condition are revealed. The improved corrosion resistance of brass in chloride media, if compared to zinc metal, is attributed to a Cu-rich layer formed by the selective dissolution of zinc. Based on the results, a structural model describing the improved corrosion resistance of Cu-40Zn alloy with respect to Zn metal is proposed.     

Pharmacologic profile of survivors of acute myocardial infarction at United States academic hospitals

Optimal drug therapy for patients with acute myocardial infarction (AMI) is well described in the medical literature. However, data on the actual pharmacologic management of patients surviving AMI at academic hospitals is unavailable. The purpose of this study was to document treatment profiles in 500 patients surviving AMI at 12 academic hospitals in the United States. These profiles were compared with established guidelines and were evaluated for trends. Overall, thrombolytics (streptokinase > or = tissue-type plasminogen activator) were administered in 29% of the patients, with a greater proportion of patients receiving beta-blockers than calcium channel antagonists in the initial 72 hours (61% vs 40%; p < 0.005) and at discharge (51% vs 35%; p < 0.005). Further, women were less likely than men to receive thrombolytic therapy (odds ratio [OR] = 0.61; confidence interval [CI], 0.54 to 0.69) or beta-blocker therapy within the first 72 hours (OR = 0.61; CI, 0.55 to 0.67) or at hospital discharge (OR = 0.53; CI, 0.48 to 0.58). Overall, improvements could still be made in the number of patients who receive thrombolytic and acute and chronic beta-blocker therapies after AMI, particularly in women. Changes in treatment profiles may be a reflection of the publication of large clinical trials.     

Exogenous Integrin αIIbβ3 Inhibitors Revisited: Past,Present and Future Applications

The integrin αIIbβ3 is the most abundant integrin on platelets. Upon platelet activation, the integrin changes its conformation (inside-out signalling) and outside-in signalling takes place leading to platelet spreading, platelet aggregation and thrombus formation. Bloodsucking parasites such as mosquitoes, leeches and ticks express anticoagulant and antiplatelet proteins, which represent major sources of lead compounds for the development of useful therapeutic agents for the treatment of haemostatic disorders or cardiovascular diseases. In addition to hematophagous parasites, snakes also possess anticoagulant and antiplatelet proteins in their salivary glands. Two snake venom proteins have been developed into two antiplatelet drugs that are currently used in the clinic. The group of proteins discussed in this review are disintegrins, low molecular weight integrin-binding cysteine-rich proteins, found in snakes, ticks, leeches, worms and horseflies. Finally, we highlight various oral antagonists, which have been tested in clinical trials but were discontinued due to an increase in mortality. No new αIIbβ3 inhibitors are developed since the approval of current platelet antagonists, and structure-function analysis of exogenous disintegrins could help find platelet antagonists with fewer adverse side effects.